These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 11212223)
1. Inducible nitric oxide synthase (iNOS) is expressed similarly in multiple aberrant crypt foci and colorectal tumors from the same patients. Hao XP; Pretlow TG; Rao JS; Pretlow TP Cancer Res; 2001 Jan; 61(2):419-22. PubMed ID: 11212223 [TBL] [Abstract][Full Text] [Related]
2. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor. Rao CV; Indranie C; Simi B; Manning PT; Connor JR; Reddy BS Cancer Res; 2002 Jan; 62(1):165-70. PubMed ID: 11782374 [TBL] [Abstract][Full Text] [Related]
3. Altered expression of beta-catenin, inducible nitric oxide synthase and cyclooxygenase-2 in azoxymethane-induced rat colon carcinogenesis. Takahashi M; Mutoh M; Kawamori T; Sugimura T; Wakabayashi K Carcinogenesis; 2000 Jul; 21(7):1319-27. PubMed ID: 10874009 [TBL] [Abstract][Full Text] [Related]
4. Beta-catenin expression is altered in human colonic aberrant crypt foci. Hao XP; Pretlow TG; Rao JS; Pretlow TP Cancer Res; 2001 Nov; 61(22):8085-8. PubMed ID: 11719432 [TBL] [Abstract][Full Text] [Related]
5. Lymphocytic infiltration and expression of inducible nitric oxide synthase in human duodenal and colonic mucosa is a characteristic feature of ankylosing spondylitis. Lamarque D; Nhieu JT; Breban M; Bernardeau C; Martin-Garcia N; Szepes Z; Delchier JC; Whittle B; Claudepierre P J Rheumatol; 2003 Nov; 30(11):2428-36. PubMed ID: 14677189 [TBL] [Abstract][Full Text] [Related]
6. Increased expression of inducible nitric oxide synthase for human oral submucous fibrosis, verrucous hyperplasia, and verrucous carcinoma. Chen YK; Hsuen SS; Lin LM Int J Oral Maxillofac Surg; 2002 Aug; 31(4):419-22. PubMed ID: 12361077 [TBL] [Abstract][Full Text] [Related]
7. Frequent nitric oxide synthase-2 expression in human colon adenomas: implication for tumor angiogenesis and colon cancer progression. Ambs S; Merriam WG; Bennett WP; Felley-Bosco E; Ogunfusika MO; Oser SM; Klein S; Shields PG; Billiar TR; Harris CC Cancer Res; 1998 Jan; 58(2):334-41. PubMed ID: 9443414 [TBL] [Abstract][Full Text] [Related]
8. Aberrant crypt foci. Alrawi SJ; Schiff M; Carroll RE; Dayton M; Gibbs JF; Kulavlat M; Tan D; Berman K; Stoler DL; Anderson GR Anticancer Res; 2006; 26(1A):107-19. PubMed ID: 16475686 [TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical expression of cytokine induced nitric oxide synthase in colorectal carcinoma. Nozoe T; Yasuda M; Honda M; Inutsuka S; Korenaga D Oncol Rep; 2002; 9(3):521-4. PubMed ID: 11956620 [TBL] [Abstract][Full Text] [Related]
10. Qualitative and quantitative relationship between dysplastic aberrant crypt foci and tumorigenesis in the Min/+ mouse colon. Paulsen JE; Steffensen IL; Løberg EM; Husøy T; Namork E; Alexander J Cancer Res; 2001 Jul; 61(13):5010-5. PubMed ID: 11431334 [TBL] [Abstract][Full Text] [Related]
11. Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer. Engelhardt M; Drullinsky P; Guillem J; Moore MA Clin Cancer Res; 1997 Nov; 3(11):1931-41. PubMed ID: 9815582 [TBL] [Abstract][Full Text] [Related]
12. Expression of inducible nitric oxide synthase (iNOS) mRNA in inflamed esophageal and colonic mucosa in a pediatric population. Gupta SK; Fitzgerald JF; Chong SK; Croffie JM; Garcia JG Am J Gastroenterol; 1998 May; 93(5):795-8. PubMed ID: 9625130 [TBL] [Abstract][Full Text] [Related]
13. Modulation of inducible nitric oxide synthase expression in rat intestinal cells by colon tumor promoters. Hirose Y; Rao CV; Reddy BS Int J Oncol; 2001 Jan; 18(1):141-6. PubMed ID: 11115551 [TBL] [Abstract][Full Text] [Related]
14. Role of inducible nitric oxide synthase expression in aberrant crypt foci-adenoma-carcinoma sequence. Xu MH; Deng CS; Zhu YQ; Lin J World J Gastroenterol; 2003 Jun; 9(6):1246-50. PubMed ID: 12800233 [TBL] [Abstract][Full Text] [Related]
15. Increased expression of inducible nitric oxide synthase for human buccal squamous-cell carcinomas: immunohistochemical, reverse transcription-polymerase chain reaction (RT-PCR) and in situ RT-PCR studies. Chen YK; Hsue SS; Lin LM Head Neck; 2002 Oct; 24(10):925-32. PubMed ID: 12369071 [TBL] [Abstract][Full Text] [Related]
16. Rectal aberrant crypt foci identified using high-magnification-chromoscopic colonoscopy: biomarkers for flat and depressed neoplasia. Hurlstone DP; Karajeh M; Sanders DS; Drew SK; Cross SS Am J Gastroenterol; 2005 Jun; 100(6):1283-9. PubMed ID: 15929758 [TBL] [Abstract][Full Text] [Related]
17. The physiological expression of inducible nitric oxide synthase (iNOS) in the human colon. Roberts PJ; Riley GP; Morgan K; Miller R; Hunter JO; Middleton SJ J Clin Pathol; 2001 Apr; 54(4):293-7. PubMed ID: 11304846 [TBL] [Abstract][Full Text] [Related]
18. Transfection of K-rasAsp12 cDNA markedly elevates IL-1beta- and lipopolysaccharide-mediated inducible nitric oxide synthase expression in rat intestinal epithelial cells. Takahashi M; Mutoh M; Shoji Y; Kamanaka Y; Naka M; Maruyama T; Sugimura T; Wakabayashi K Oncogene; 2003 Oct; 22(48):7667-76. PubMed ID: 14576830 [TBL] [Abstract][Full Text] [Related]
19. Sequential expression of inducible nitric oxide synthase and cyclooxygenase-2 during DMBA-induced hamster buccal pouch carcinogenesis. Kim SA; Ahn SG; Kim DK; Kim SG; Lee SH; Kim J; Yoon JH In Vivo; 2004; 18(5):609-14. PubMed ID: 15523901 [TBL] [Abstract][Full Text] [Related]
20. [Expression of inducible nitric oxide synthase in human esophageal biopsies from carcinoma and precancerous lesions]. Jin Y; Zhang W; Liu B; Wang H; Han Z; Wang L; Liu Y; Jin Y; Qu P; Li M; Ding Z; Lin P Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2000 Dec; 22(6):570-2. PubMed ID: 12903407 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]